These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 27876897
1. MMPs and TIMPs expression in facial tissue of children with cleft lip and palate. Smane-Filipova L, Pilmane M, Akota I. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):538-542. PubMed ID: 27876897 [Abstract] [Full Text] [Related]
2. Immunohistochemical analysis of nestin, CD34 and TGFβ3 in facial tissue of children with complete unilateral and bilateral cleft lip and palate. Smane-Filipova L, Pilmane M, Akota I. Stomatologija; 2016 Dec; 18(3):98-104. PubMed ID: 28386053 [Abstract] [Full Text] [Related]
3. Apoptosis and MMP-2, TIMP-2 expression in cleft lip and palate. Smane L, Pilmane M, Akota I. Stomatologija; 2013 Dec; 15(4):129-34. PubMed ID: 24589636 [Abstract] [Full Text] [Related]
4. Evaluation of the presence of MMP-2, TIMP-2, BMP2/4, and TGFβ3 in the facial tissue of children with cleft lip and palate. Smane L, Pilmane M. Acta Med Litu; 2018 Dec; 25(2):86-94. PubMed ID: 30210242 [Abstract] [Full Text] [Related]
5. TGF-beta3-induced palatogenesis requires matrix metalloproteinases. Blavier L, Lazaryev A, Groffen J, Heisterkamp N, DeClerck YA, Kaartinen V. Mol Biol Cell; 2001 May; 12(5):1457-66. PubMed ID: 11359935 [Abstract] [Full Text] [Related]
6. Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease. Verstappen J, Von den Hoff JW. J Dent Res; 2006 Dec; 85(12):1074-84. PubMed ID: 17122157 [Abstract] [Full Text] [Related]
7. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Fondard O, Detaint D, Iung B, Choqueux C, Adle-Biassette H, Jarraya M, Hvass U, Couetil JP, Henin D, Michel JB, Vahanian A, Jacob MP. Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062 [Abstract] [Full Text] [Related]
8. The role of TIMPs in regulation of extracellular matrix proteolysis. Arpino V, Brock M, Gill SE. Matrix Biol; 2015 Jul; 44-46():247-54. PubMed ID: 25805621 [Abstract] [Full Text] [Related]
9. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling. Wang W, Zhang HT, Yang XL. J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563 [Abstract] [Full Text] [Related]
10. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes. Pan CH, Wen CH, Lin CS. Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491 [Abstract] [Full Text] [Related]
11. Differential expression of remodeling markers by tissue structure in nasal polyposis. de Borja Callejas F, Picado C, Martínez-Antón A, Alobid I, Pujols L, Valero A, Roca-Ferrer J, Mullol J. Am J Rhinol Allergy; 2013 May; 27(3):e69-74. PubMed ID: 23710947 [Abstract] [Full Text] [Related]
12. Involvement of matrix metalloproteinases and their inhibitors in endometrial extracellular matrix turnover in Chlamydia trachomatis-infected recurrent spontaneous aborters. Singh N, Prasad P, Das B, Rastogi S. Pathog Dis; 2017 Jan 01; 75(1):. PubMed ID: 28115359 [Abstract] [Full Text] [Related]
13. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. Gaide Chevronnay HP, Selvais C, Emonard H, Galant C, Marbaix E, Henriet P. Biochim Biophys Acta; 2012 Jan 01; 1824(1):146-56. PubMed ID: 21982799 [Abstract] [Full Text] [Related]
14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis. Cheung C, Luo H, Yanagawa B, Leong HS, Samarasekera D, Lai JC, Suarez A, Zhang J, McManus BM. Cardiovasc Pathol; 2006 Jan 01; 15(2):63-74. PubMed ID: 16533694 [Abstract] [Full Text] [Related]
15. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases. Li X, de Boer OJ, Ploegmaker H, Teeling P, Daemen MJ, de Winter RJ, van der Wal AC. Cardiovasc Pathol; 2016 Jan 01; 25(1):40-6. PubMed ID: 26490693 [Abstract] [Full Text] [Related]
16. Temporospatial distribution of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinases during murine secondary palate morphogenesis. Morris-Wiman J, Burch H, Basco E. Anat Embryol (Berl); 2000 Aug 01; 202(2):129-41. PubMed ID: 10985432 [Abstract] [Full Text] [Related]
17. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K, Shigemasa K, Nagai N, Ohama K. Int J Oncol; 2000 Oct 01; 17(4):673-81. PubMed ID: 10995877 [Abstract] [Full Text] [Related]
18. Evaluation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in human cases with orofacial clefts: A systematic review. Imani MM, Shalchi M, Ahmadabadi G, Sadeghi M. Int Orthod; 2023 Sep 01; 21(3):100781. PubMed ID: 37301105 [Abstract] [Full Text] [Related]
19. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus. Shukla V, Kumar Shakya A, Dhole TN, Misra UK. Neuroimmunomodulation; 2012 Sep 01; 19(4):241-54. PubMed ID: 22441541 [Abstract] [Full Text] [Related]
20. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease. Rosemar A, Ivarsson ML, Börjesson L, Holmdahl L. Scand J Gastroenterol; 2007 Feb 01; 42(2):215-20. PubMed ID: 17327941 [Abstract] [Full Text] [Related] Page: [Next] [New Search]